Glazer Capital’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-23,900
Closed -$7K – 430
2025
Q3
$7K Sell
23,900
-26,100
-52% -$7.07K ﹤0.01% 295
2025
Q2
$12K Hold
50,000
– – ﹤0.01% 227
2025
Q1
$7K Buy
+50,000
New +$8.8K ﹤0.01% 175

Other funds holding TDACW

Glazer Capital's TDACW Position: Q4 2025 in Review

Glazer Capital sold out of Translational Development Acquisition Corp Warrants (TDACW) in Q4 2025, closing a stake of 23,900 shares — an estimated $7K sold.

Glazer Capital first reported a position in TDACW in Q1 2025 and held it in 3 quarters. The position peaked at $12K in Q2 2025. 33 funds tracked by Wall St. Rank hold TDACW as of Q4 2025.

  • Glazer Capital reported no remaining Translational Development Acquisition Corp Warrants position as of Q4 2025 after selling out during the quarter.
  • Glazer Capital sold 23,900 Translational Development Acquisition Corp Warrants shares in Q4 2025, an estimated $7K.
  • Glazer Capital first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and held it in 3 quarters.
  • Glazer Capital's Translational Development Acquisition Corp Warrants position peaked at $12K in Q2 2025.
  • 33 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q4 2025.

Based on Glazer Capital's 13F filing for Q4 2025, filed 13 Feb 2026.